Request Trial
patent
Tashatuvango / shutterstock.com
10 November 2016

University of California takes more action over AFib patents

The regents of the University of California, the institution’s governing body, has filed a  complaint against US-based medical device company AtriCure for allegedly infringing patents covering a method of treating atrial fibrillation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Benesch adds former McDermott IP practice head
21 September 2026   The hire brings more than three decades of experience across patent litigation, prosecution, licensing and cross-border matters, advising clients in the medical devices, automotive, manufacturing, consumer products, software and electronics sectors.
Careers
Leading European patent litigator to join Carpmaels & Ransford
18 September 2026   The new hire brings more than two decades’ experience managing complex cross-border disputes in life sciences and technology, including most recently at the Unified Patent Court.
In-house counsel
CIPA Congress: Sustainability is essential for the profession and the planet
18 September 2026   At an event attended by patent experts and judges from Europe, the US and China, delegates gathered in the innovation hub of Manchester, UK, to debate the theme of sustainability "in its broadest sense". Sarah Speight was there to hear ideas spanning the commercialisation of clean tech, to ensuring the patent profession’s resilience in a time of colossal change.


Editor's picks

Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

Editor's picks

Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

More features

Benesch adds former McDermott IP practice head
Leading European patent litigator to join Carpmaels & Ransford
CIPA Congress: Sustainability is essential for the profession and the planet
Non-profit sues Cambrex over anticancer drug manufacturing trade secrets
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Amgen hit with lawsuit over its proposed Opdivo biosimilar
Australian biotech sues Grail over multi-cancer blood test
K&L Gates hires six-strong team of IP and corporate lawyers from Pillsbury